Loading…
Dyne Therapeutics, Inc. is projected to rise to $29.57 by 2027, a +26% move from its current price of $23.42. DYN is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/13/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $22.75 | $23.43 | $24.13 | +0.04% |
| Jul 15 | $22.48 | $23.44 | $24.44 | +0.09% |
| Jul 16 | $22.28 | $23.45 | $24.68 | +0.13% |
| Jul 17 | $22.11 | $23.46 | $24.89 | +0.17% |
| Jul 18 | $21.97 | $23.47 | $25.07 | +0.21% |
| Jul 19 | $21.84 | $23.48 | $25.24 | +0.26% |
| Jul 20 | $21.72 | $23.49 | $25.40 | +0.30% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $21.72 | $23.49 | $25.40 | +0.30% |
| Week 2 | $21.09 | $23.56 | $26.31 | +0.60% |
| Week 3 | $20.64 | $23.63 | $27.06 | +0.90% |
| Week 4 | $20.27 | $23.70 | $27.71 | +1.20% |
| Week 5 | $19.96 | $23.77 | $28.31 | +1.51% |
| Week 6 | $19.69 | $23.84 | $28.88 | +1.81% |
| Week 7 | $19.45 | $23.92 | $29.41 | +2.11% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc.
was incorporated in 2017 and is headquartered in Waltham, Massachusetts.
Dyne Therapeutics, Inc. (DYN) operates in the Healthcare sector and is currently priced at $23.07 per share with a market capitalization of $3.81B. The stock is ranked 1545 by market capitalization and size.
The 30-day trading range spans $18.70 to $28.45, providing a sense of recent volatility within a defined band. The stock shows bullish sentiment with RSI(14) at 70, and it trades above both its 50-day and 200-day simple moving averages at $18.59 and $18.03 respectively. Support is marked at $16.81 and resistance at $23.07, with an annualized volatility of 60%.
These factors frame a price path that blends near-term technicals with a long-run forecast.
A major floor 40.1% below — a decisive break under it would weaken the trend.
The nearest floor, 28.2% below — buyers have tended to step in here.
The nearest ceiling, 3.6% above — a clean break opens room to run.
A major ceiling 23.7% above — clearing it would confirm fresh momentum.
Key DYN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of DYN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $23.64 | Sell | $23.48 | Sell |
| MA 10 | $22.75 | Buy | $22.76 | Buy |
| MA 20 | $21.07 | Buy | $21.54 | Buy |
| MA 50 | $19.09 | Buy | $19.91 | Buy |
| MA 100 | $18.41 | Buy | $18.97 | Buy |
| MA 200 | $18.28 | Buy | $18.14 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 66.20 | Neutral |
| Stoch RSI (14) | 42.85 | Neutral |
| CCI (20) | 92.79 | Neutral |
| Williams %R (14) | -21.20 | Info |
| MACD (12,26,9) | 0.27 | Buy |
| ROC (12) | 15.60 | Buy |
| Bollinger %B (20,2) | 0.80 | Neutral |
| Stochastic %K (14) | 78.80 | Neutral |
| TRIX (15) | 0.89 | Buy |
| Awesome (5,34) | 3.87 | Buy |
| Ultimate (7,14,28) | 66.48 | Neutral |
| Momentum (10) | 2.81 | Buy |
| Aroon Osc (25) | 84.00 | Buy |
| Hull MA (9) | 24.35 | Sell |
| ADX (14) | 26.17 | Buy |
| ATR (14) | 0.58 | Info |
The 30-day picture is bullish, with RSI(14) at 70 and the price sitting above the 50-day SMA of $18.59 and the 200-day SMA of $18.03. Near-term momentum is influenced by the defined resistance at $23.07 and support at $16.81, framing a channel around the current price level. The 30-day range runs from $18.70 to $28.45, highlighting a window of potential movement as market conditions unfold.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $14.60 | $23.42 | $31.73 | 0% | Neutral | |
| $23.37 | $29.57 | $39.70 | +26% | Bullish | |
| $26.62 | $34.73 | $48.50 | +48% | Bullish | |
| $26.85 | $35.94 | $51.76 | +53% | Bullish | |
| $30.71 | $42.03 | $62.13 | +79% | Bullish | |
| $38.97 | $54.44 | $82.31 | +132% | Bullish | |
| $44.86 | $63.87 | $98.55 | +173% | Bullish | |
| $51.15 | $74.14 | $116.51 | +217% | Bullish | |
| $50.92 | $75.07 | $119.98 | +221% | Bullish | |
| $51.16 | $76.67 | $124.46 | +227% | Bullish | |
| $84.86 | $137.00 | $237.38 | +485% | Bullish | |
| $170.08 | $312.55 | $595.35 | +12.3x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $14.60 | $23.42 | $28.12 | +0.00% |
| August 2026 | $19.90 | $23.53 | $28.60 | +0.47% |
| September 2026 | $20.44 | $24.35 | $29.96 | +3.48% |
| October 2026 | $20.96 | $25.14 | $31.24 | +3.23% |
| November 2026 | $20.66 | $24.91 | $31.23 | -0.89% |
| December 2026 | $20.72 | $25.12 | $31.73 | +0.83% |
Click any year to see its month-by-month DYN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The DYN price prediction for 2026 points to an average of $23.42 (low $14.60, high $31.73) — a potential gain of 0% on today's $23.42. Price action looks broadly range-bound.
In 2027, DYN is projected to trade between $23.37 and $39.70, averaging $29.57 — a potential gain of +26% from today's $23.42. That is up +26% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Dyne Therapeutics, Inc.'s 2028 outlook centres on $34.73, within a $26.62 to $48.50 range. That is up +17% on the projected 2027 average. That marks a +48% change versus current levels. Momentum favours further upside here.
By 2029, DYN could reach as high as $51.76, with a base case around $35.94 and support toward $26.85 — roughly +53% from $23.42. Buyers look set to stay in control over this stretch.
Expect DYN to range from $30.71 to $62.13 through 2030. The $42.03 average target implies a +79% move from current prices. That is up +17% on the projected 2029 average. Momentum favours further upside here.
The DYN price prediction for 2031 points to an average of $54.44 (low $38.97, high $82.31) — a potential gain of +132% on today's $23.42. Buyers look set to stay in control over this stretch.
In 2032, DYN is projected to trade between $44.86 and $98.55, averaging $63.87 — a potential gain of +173% from today's $23.42. That is up +17% on the projected 2031 average. Momentum favours further upside here.
Dyne Therapeutics, Inc.'s 2033 outlook centres on $74.14, within a $51.15 to $116.51 range. That is up +16% on the projected 2032 average. That marks a +217% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, DYN could reach as high as $119.98, with a base case around $75.07 and support toward $50.92 — roughly +221% from $23.42. Momentum favours further upside here.
Expect DYN to range from $51.16 to $124.46 through 2035. The $76.67 average target implies a +227% move from current prices. That is up +2% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The DYN price prediction for 2040 points to an average of $137.00 (low $84.86, high $237.38) — a potential gain of +485% on today's $23.42. Momentum favours further upside here.
In 2050, DYN is projected to trade between $170.08 and $595.35, averaging $312.55 — a potential gain of +12.3x from today's $23.42. That is up +128% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in DYN today (≈ 42.698548 DYN) could be worth
$13,345.61
+$12,345.61 (+1235%) by 2050 · US Dollar
Based on the average projected DYN price of $312.55 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in DYNwould be worth at today's price.
$1,000 invested in DYN on Jul 10, 2025 (≈ 113.636361 DYN) would be worth
$2,661.36
+$1,661.36 (+166.1%) today · 2.66× · US Dollar
Based on a DYN entry price of $8.8 vs. today's $23.42.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $23.07 | $1,015.17 | +1.5% |
| 1 month ago | $17.67 | $1,325.41 | +32.5% |
| 3 months ago | $18.68 | $1,253.75 | +25.4% |
| 6 months ago | $17.46 | $1,341.35 | +34.1% |
| 1 year ago | $8.8 | $2,661.36 | +166.1% |
| All time (5.0y) ago | $18.48 | $1,267.32 | +26.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our DYN forecast.
Our base-case forecast reaches $47.00 around 2031.
Implied market cap at $47.00: $7.77B
The multi-year forecast shows a bullish trajectory over time, with the average price rising from $23.07 in 2026 to higher levels through 2030, 2040 and beyond. The 2030 forecast average is $41.40 with a max of $62.27 and a min of $29.79, yielding a 79.5 ROI and a bullish sentiment. The 2040 forecast average is $135.58 with a max of $241.00 and a min of $81.32, yielding a 487.7 ROI and a bullish sentiment.
The 2050 forecast average is $319.66 with a max of $627.41 and a min of $165.84, yielding a 1285.6 ROI and a bullish sentiment. These estimates illustrate substantial upside potential over the long term, but they are not guarantees and actual results may vary due to market and clinical development factors.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $41.40, with a min of $29.79 and a max of $62.27; ROI 79.5; sentiment BULLISH.
The forecast begins neutral in 2026 (avg $23.07, min $14.60, max $31.98; ROI 0) and trends bullish thereafter, with 2027 avg $29.36 and 2050 avg $319.66, ROI 1285.6; sentiment remains BULLISH across the longer horizon.
Yes. The 2030 max forecast is $62.27, which exceeds $60.
Current price is $23.07 and market cap is $3.81B.
The 30-day range is $18.70 to $28.45.
Dyne Therapeutics, Inc. Community Discussion
0Share your Dyne Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.